2008Clinical MedicineRequires access

Effects of intravenous diltiazem for treatment of rapid ventricular rate in atrial fibrillation

Geng Yutin

Open publisher page 0 citations

Abstract

Objective To evaluate the effect and safety of intravenous diltiazem for treatment of rapid ventricular rate in atrial fibrillation.Methods Sixty-six patients with rapid atrial fibrillation were divided into two groups(the treatment group and the control group) by a single-blind.Thirty-four cases(the treatment group) were applied by intravenous diltiazem and others by cedilanid.Results The total effective rate of the treatment group was 94.11% and the other was 68.75%.Efficacy in the treatment group was better than that in the control group,there had significant difference(P0.05).No serious adverse reaction happened due to diltiazem.Conclusion Diltiazem is more rapidly,effectively and safely than cedilanid in acutely slowing of rapid ventricular rate in patients with atrial fibrillation.

About this research paper

What this paper is about

Objective To evaluate the effect and safety of intravenous diltiazem for treatment of rapid ventricular rate in atrial fibrillation.Methods Sixty-six patients with rapid atrial fibrillation were divided into two groups(the treatment group and the control group) by a single-blind.Thirty-four cases(the treatment group) were applied by intravenous diltiazem and others by cedilanid.Results The total effective rate of the treatment group was 94.11% and the other was 68.75%.Efficacy in the treatment group was better than that in the control group,there had significant difference(P0.05).No serious adverse reaction happened due to diltiazem.Conclusion Diltiazem is more rapidly,effectively and safely than cedilanid in acutely slowing of rapid ventricular rate in patients with atrial fibrillation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effect and safety of intravenous diltiazem for treatment of rapid ventricular rate in atrial fibrillation.Methods Sixty-six patients with rapid atrial fibrillation were divided into two groups(the treatment group and the control group) by a single-blind.Thirty-four cases(the treatment group) were applied by intravenous diltiazem and others by cedilanid.Results The total effective rate of the treatment group was 94.11% and the other was 68.75%.Efficacy in the treatment group was better than that in the control group,there had significant difference(P0.05).No serious adverse reaction happened due to diltiazem.Conclusion Diltiazem is more rapidly,effectively and safely than cedilanid in acutely slowing of rapid ventricular rate in patients with atrial fibrillation.

Key concepts: Diltiazem, Medicine, Atrial fibrillation, Ventricular rate, Cardiology, Anesthesia, Adverse effect, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of intravenous diltiazem for treatment of rapid ventricular rate in atrial fibrillation — Research Paper | ScholarLens